The two screening methods have similar sensitivity and specificity in finding microcalcifications.
Synthetic mammography (SM) plus digital breast tomosynthesis (DBT) find microcalcifications at a similar rate as full-field digital mammography (FFDM) alone, according to a study published in the journal Radiology.
Researchers from Taiwan and the United States performed a retrospective study to compare the performance of SM plus DBT with FFDM in the detection of microcalcifications on screening mammograms.
Related article:Â Breast Density Estimations in Standard-dose, Synthetic Mammograms
The researchers reviewed 72 consecutive screening mammograms recalled for microcalcifications and 20 controls, evaluated with both FFDM and DBT:
FFDM alone was compared to synthetic mammography plus DBT. Four readers independently reviewed each data set and microcalcification recalls were tabulated.
The results showed that the reader agreement was kappa value of 0.66 for FFDM and 0.63 for SM plus DBT. Mixed-effects model concluded no differences between modalities.
Â
The researchers concluded that relative to FFDM, SM plus DMT had similar sensitivity and specificity for the detection of microcalcifications previously identified for recall at screening mammography.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Mammography Study: AI Facilitates Greater Accuracy and Longer Fixation Time on Suspicious Areas
July 8th 2025While noting no differences in sensitivity, specificity or reading time with adjunctive AI for mammography screening, the authors of a new study noted a 4 percent higher AUC and increased fixation time on lesion regions.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.